Product logins

Find logins to all Clarivate products below.


Urological Devices | Market Insights | Asia Pacific | 2022

The deferral or cancellation of nonessential procedures due to the COVID-19 pandemic negatively impacted the Asia Pacific urological device market in 2020; however, the market will show strong recovery in 2021. Following the short-term impact of the global pandemic, the market will continue to expand through 2030 due to growing patient awareness of urological treatments in this region. In particular, rising use of minimally invasive laser treatments in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in Asia Pacific across an 11-year period.

Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…